Globe Life (NYSE:GL – Get Free Report) is anticipated to post its Q2 2025 quarterly earnings results after the market closes on Wednesday, July 23rd. Analysts expect the company to announce earnings of $3.27 per share and revenue of $1.50 billion for the quarter. Globe Life has set its FY 2025 guidance at 13.450-14.050 EPS.
Globe Life (NYSE:GL – Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $3.07 earnings per share for the quarter, missing analysts’ consensus estimates of $3.24 by ($0.17). Globe Life had a return on equity of 21.44% and a net margin of 18.33%. The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.49 billion. During the same quarter last year, the company earned $2.78 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, analysts expect Globe Life to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.
Globe Life Trading Down 2.3%
Globe Life stock opened at $117.87 on Wednesday. The stock has a 50-day moving average of $120.88 and a two-hundred day moving average of $121.36. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life has a one year low of $86.10 and a one year high of $133.76. The stock has a market cap of $9.73 billion, a PE ratio of 9.59 and a beta of 0.56.
Globe Life Dividend Announcement
Insider Activity at Globe Life
In other Globe Life news, CEO Frank M. Svoboda sold 6,019 shares of the business’s stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $122.51, for a total value of $737,387.69. Following the completion of the sale, the chief executive officer owned 31,298 shares of the company’s stock, valued at $3,834,317.98. The trade was a 16.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.97% of the stock is currently owned by company insiders.
Institutional Trading of Globe Life
A number of large investors have recently made changes to their positions in GL. Acadian Asset Management LLC bought a new position in Globe Life in the first quarter valued at approximately $322,000. Empowered Funds LLC bought a new position in Globe Life in the first quarter valued at approximately $428,000. NewEdge Advisors LLC grew its stake in Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares in the last quarter. Focus Partners Wealth boosted its stake in shares of Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after acquiring an additional 656 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Globe Life by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after acquiring an additional 607 shares during the period. Institutional investors own 81.61% of the company’s stock.
Wall Street Analyst Weigh In
GL has been the topic of a number of research analyst reports. Morgan Stanley set a $127.00 target price on Globe Life and gave the company an “equal weight” rating in a research report on Monday. Wall Street Zen upgraded Globe Life from a “hold” rating to a “buy” rating in a research report on Friday, May 16th. Piper Sandler reduced their target price on Globe Life from $152.00 to $147.00 and set an “overweight” rating on the stock in a research report on Friday, May 2nd. Truist Financial initiated coverage on Globe Life in a research report on Tuesday. They issued a “buy” rating and a $150.00 target price on the stock. Finally, JPMorgan Chase & Co. lifted their target price on Globe Life from $145.00 to $160.00 and gave the company an “overweight” rating in a research report on Tuesday, July 8th. Three research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $143.82.
Read Our Latest Research Report on GL
About Globe Life
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Articles
- Five stocks we like better than Globe Life
- What Is WallStreetBets and What Stocks Are They Targeting?
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.